Showing posts with label
clonoSEQ
.
Show all posts
Showing posts with label
clonoSEQ
.
Show all posts
Friday, August 9, 2024
The partnership between Microsoft and Adaptive Biotechnologies represents a convergence of biotechnology, Ai, medicine and advanced computing, to unlock the secrets of the immune system.
›
Adaptive Biotechnologies Inc. (ticker: ADPT ) is a biotechnology company that specializes in using the adaptive immune system's capabi...
Thursday, July 25, 2024
Adaptive Biotechnologies (ADPT on Nasdaq) is making significant advancements in biotechnology, focusing on harnessing the adaptive immune system for diagnosing and treating diseases
›
One of their primary areas of development is in T-cell receptor (TCR) therapeutics. They have identified and characterized over 8,000 uniq...
›
Home
View web version
